Hypochlorous Acid Can Be the Novel Option for the Meibomian Gland Dysfunction Dry Eye through Ultrasonic Atomization

Table 2

Summary of efficacy endpoints between hypochlorous acid (HOCL) and placebo groups.

Visit duration	HOCL (),	Placebo (),	value by ANOVA for HOCL vs. placebo
(a) Ocular surface disease index (OSDI) scores
1^st day			0.058
15^th day			0.061
30^th day			0.055
55^th day			0.052
(b) Schirmer’s test average of both eyes
1^st day			0.411
15^th day			0.053
30^th day			<0.05
55^th day			<0.01
(c) Tear film break-up time (TBUT) average of both eyes
1^st day			0.423
15^th day			0.351
30^th day			0.459
55^th day			<0.05
(d) Conjunctivae labeling average of both eyes
1^st day			0.677
55^th day			<0.01
(e) Corneal labeling average of both eyes
1^st day			0.406
55^th day			<0.05